Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021)
Rhythm Pharmaceuticals' (RYTM) quarterly Non-Current Deferred Tax Liability came in at $8.0 million in Q3 2021, down 52.96% on a QoQ basis from $17.0 million in Q2 2021.
Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $8.0 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 7.99 Mn |
| Sep 30, 2021 | 7.99 Mn |
| Jun 30, 2021 | 16.98 Mn |
| Jun 30, 2021 | 16.98 Mn |
| Mar 31, 2021 | 22.01 Mn |
| Mar 31, 2021 | 22.01 Mn |